These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 25756294)

  • 1. Community pharmacists' role in benzodiazepine supply in Ireland: a questionnaire of pharmacists' views and experiences.
    Cadogan CA; Ryder SA
    Int J Pharm Pract; 2015 Dec; 23(6):415-22. PubMed ID: 25756294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of community chain pharmacists' interventions on electronic prescriptions.
    Warholak TL; Rupp MT
    J Am Pharm Assoc (2003); 2009; 49(1):59-64. PubMed ID: 19196598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers?
    Aburuz S; Al-Ghazawi M; Snyder A
    Int J Pharm Pract; 2012 Apr; 20(2):71-9. PubMed ID: 22416931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists.
    George J; Pfleger D; McCaig D; Bond C; Stewart D
    Pharm World Sci; 2006 Apr; 28(2):45-53. PubMed ID: 16752193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacists' awareness, identification, and management of prescribing cascades: A cross-sectional survey.
    Dalton K; Callaghan R; O'Sullivan N; McCarthy L
    Res Social Adm Pharm; 2024 Jun; 20(6):102-112. PubMed ID: 38768989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional survey of community pharmacists' views of the electronic Minor Ailment Service in Scotland.
    Paudyal V; Hansford D; Scott Cunningham IT; Stewart D
    Int J Pharm Pract; 2010 Aug; 18(4):194-201. PubMed ID: 20636670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
    Alzubaidi H; Saidawi W; Mc Namara K
    Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist prescribing: a cross-sectional survey of the views of pharmacists in Nigeria.
    Auta A; Strickland-Hodge B; Maz J; David S
    Int J Pharm Pract; 2018 Apr; 26(2):111-119. PubMed ID: 28497878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services.
    Kritikos VS; Reddel HK; Bosnic-Anticevich SZ
    Int J Pharm Pract; 2010 Aug; 18(4):209-16. PubMed ID: 20636672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community pharmacists' opinions on skill-mix and delegation in England.
    Barnes E; Bullock A; Allan M; Hodson K
    Int J Pharm Pract; 2018 Oct; 26(5):398-406. PubMed ID: 29210132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Views and experiences of community pharmacists and superintendent pharmacists regarding the New Medicine Service in England prior to implementation.
    Wells KM; Thornley T; Boyd MJ; Boardman HF
    Res Social Adm Pharm; 2014; 10(1):58-71. PubMed ID: 23608701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
    Gordon C; Unni E; Montuoro J; Ogborn DB
    Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
    Mandt I; Horn AM; Ekedahl A; Granas AG
    Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacists' opportunities to reduce inappropriate prescription of QT-prolonging medications: calls to action.
    Dhanani TC; Mantovani EH; Turner JR
    Int J Pharm Pract; 2017 Apr; 25(2):176-179. PubMed ID: 27677250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community pharmacists' opinions and practice of pharmaceutical care at chain pharmacy and independent pharmacy in China.
    Xi X; Huang Y; Lu Q; Ung COL; Hu H
    Int J Clin Pharm; 2019 Apr; 41(2):478-487. PubMed ID: 30864081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing oral chemotherapy services in community pharmacies: a qualitative study of chemotherapy nurses' and pharmacists' views.
    Butt F; Ream E
    Int J Pharm Pract; 2016 May; 24(3):149-59. PubMed ID: 26671523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the General Practitioner-pharmacist relationship in the community setting in Ireland.
    Moore T; Kennedy J; McCarthy S
    Int J Pharm Pract; 2014 Oct; 22(5):327-34. PubMed ID: 24433551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative analysis of community pharmacists' opinions on their involvement in reducing potentially inappropriate prescribing.
    Hansen CR; Byrne S; O'Mahony D; Kearney PM; Sahm LJ
    Eur J Clin Pharmacol; 2019 Feb; 75(2):265-274. PubMed ID: 30343483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.